Investment Focus

The growth engines of Evonik provide four broad areas of focus:

• Health & Care
• Smart Materials
• Animal Nutrition
• Specialty Additives

Companies with solutions to problems that address these four growth engines and/or enhance the digital transformation, are of relevance. In addition our deal flow sourcing also supports the six growth fields of Evonik.

• a clear growth strategy
• a highly motivated, focused management team
• a clear, distinctive selling point
• a secure IP position

With EUR 250 million under management, we generally maintain a minority share and are able to invest up to EUR 15 million per company

• in early-stage companies with an established proof of concept, typically in series A & B rounds
• in later-stage companies looking to accelerate growth
• typically in syndication with other venture capital investors

Successfully implementing a growth strategy requires more than just money. Evonik as one of the world’s leading providers of specialty chemicals brings additional strategic capabilities to the partnership.

• Technological expertise and infrastructure
• Market experience and access
• A global distribution network
• Expertise in patent strategies and on issues of industrial property rights

We invest globally with a focus on Europe, North America and Asia.